Top

Published in:

01-12-2010 | Topic Review

Effects of irradiation on tumor cell survival, invasion and angiogenesis

Authors: Odysseas Kargiotis, Aliki Geka, Jasti S. Rao, Athanasios P. Kyritsis

Published in: Journal of Neuro-Oncology | Issue 3/2010

Abstract

Ionizing irradiation is a widely applied therapeutic method for the majority of solid malignant neoplasms, including brain tumors where, depending on localization, this might often be the only feasible primary intervention.Without doubt, it has been proved to be a fundamental tool available in the battlefield against cancer, offering a clear survival benefit in most cases. However, numerous studies have associated tumor irradiation with enhanced aggressive phenotype of the remaining cancer cells. A cell population manages to survive after the exposure, either because it receives sublethal doses and/or because it successfully utilizes the repair mechanisms. The biology of irradiated cells is altered leading to up-regulation of genes that favor cell survival, invasion and angiogenesis. In addition, hypoxia within the tumor mass limits the cytotoxicity of irradiation, whereas irradiation itself may worsen hypoxic conditions, which also contribute to the generation of resistant cells. Activation of cell surface receptors, such as the epidermal growth factor receptor, utilization of signaling pathways, and over-expression of cytokines, proteases and growth factors, for example the matrix metalloproteinases and vascular endothelial growth factor, protect tumor and non-tumor cells from apoptosis, increase their ability to invade to adjacent or distant areas, and trigger angiogenesis. This review will try to unfold the various molecular events and interactions that control tumor cell survival, invasion and angiogenesis and which are elicited or influenced by irradiation of the tumor mass, and to emphasize the importance of combining irradiation therapy with molecular targeting.

Owen JB, Coia LR, Hanks GE (1992) Recent patterns of growth in radiation therapy facilities in the United States: a patterns of care study report. Int J Radiat Oncol Biol Phys 24(5):983–986PubMed

Prise KM, Schettino G, Folkard M, Held KD (2005) New insights on cell death from radiation exposure. Lancet Oncol 6(7):520–528PubMedCrossRef

Goldman M (1982) Ionizing radiation and its risks. West J Med 137(6):540–547PubMed

Levin VA, Maor MH, Thall PF, Yung WK, Bruner J, Sawaya R, Kyritsis AP, Leeds N, Woo S, Rodriguez L et al (1995) Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 33(2):357–364PubMed

Levin VA, Yung WK, Bruner J, Kyritsis A, Leeds N, Gleason MJ, Hess KR, Meyers CA, Ictech SA, Chang E, Maor MH (2002) Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas. Int J Radiat Oncol Biol Phys 53(1):58–66PubMed

Thornton AF Jr, Sandler HM, Ten Haken RK, McShan DL, Fraass BA, La Vigne ML, Yanke BR (1992) The clinical utility of magnetic resonance imaging in 3-dimensional treatment planning of brain neoplasms. Int J Radiat Oncol Biol Phys 24(4):767–775PubMed

Levin VA, Giglio P, Kyritsis AP (1995) The management of gliomas, medulloblastoma, CNS germ cell tumors, and carcinomas metastatic to the CNS. In: Cavalli F, Hansen H, Kaye S (eds) Textbook of medical oncology. Martin Dunitz, London, pp 415–430

Loeffler J, Alexander EI, Shea WM, Wen PY, Fine HA, Kooy HM, Black PM (1992) Radiosurgery as part of the initial management of patients with malignant gliomas. J Clin Oncol 10:1379–1385PubMed

Leach JK, Black SM, Schmidt-Ullrich RK, Mikkelsen RB (2002) Activation of constitutive nitric-oxide synthase activity is an early signaling event induced by ionizing radiation. J Biol Chem 277(18):15400–15406PubMedCrossRef

10.

Prise KM, O’Sullivan JM (2009) Radiation-induced bystander signalling in cancer therapy. Nat Rev Cancer 9(5):351–360PubMedCrossRef

11.

Bozec A, Formento P, Ciccolini J et al (2005) Response of endothelial cells to a dual tyrosine kinase receptor inhibition combined with irradiation. Mol Cancer Ther 4(12):1962–1971PubMedCrossRef

12.

Sonveaux P, Brouet A, Havaux X et al (2003) Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy. Cancer Res 63(5):1012–1019PubMed

13.

Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W (2001) Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res 61(6):2744–2750PubMed

14.

Von Essen CF (1991) Radiation enhancement of metastasis: a review. Clin Exp Metastasis 9(2):77–104CrossRef

15.

Abdollahi A, Lipson KE, Han X et al (2003) SU5416 and SU668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro. Cancer Res 63(13):3755–3763PubMed

16.

Hovinga KE, Stalpers LJ, van Bree C et al (2005) Radiation-enhanced vascular endothelial growth factor (VEGF) secretion in glioblastoma multiforme cell lines—a clue to radioresistance? J Neurooncol 74(2):99–103PubMedCrossRef

17.

Sheng-Hua C, Yan-Bin M, Zhi-An Z et al (2007) Radiation-enhanced hepatocyte growth factor secretion in malignant glioma cell lines. Surg Neurol 68(6):610–613PubMedCrossRef

18.

Dent P, Reardon DB, Park JS et al (1999) Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death. Mol Biol Cell 10(8):2493–2506PubMed

19.

Yacoub A, Miller A, Caron RW (2006) Radiotherapy-induced signal transduction. Endocr Relat Cancer 13(Suppl 1):S99–114PubMedCrossRef

20.

Cosaceanu D, Budgie RA, Lewensohn R, Dricu A (2007) Ionizing radiation activates IGF-1R triggering a cytoprotective signaling by interfering with Ku-DNA binding and by modulating Ku86 expression via a p38 kinase-dependent mechanism. Oncogene 26(17):2423–2434PubMedCrossRef

21.

Dent P, Yacoub A, Fisher PB, Hagan MP, Grant S (2003) MAPK pathways in radiation responses. Oncogene 22(37):5885–5896PubMedCrossRef

22.

Kargiotis O, Chetty C, Gondi CS et al (2008) Adenovirus-mediated transfer of siRNA against MMP-2 mRNA results in impaired invasion and tumor-induced angiogenesis, induces apoptosis in vitro and inhibits tumor growth in vivo in glioblastoma. Oncogene 27(35):4830–4840PubMedCrossRef

23.

Cheng JC, Chou CH, Kuo ML, Hsieh CY (2006) Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway. Oncogene 25(53):7009–7018PubMedCrossRef

24.

Park CM, Park MJ, Kwak HJ et al (2006) Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways. Cancer Res 66(17):8511–8519PubMedCrossRef

25.

Kargiotis O, Chetty C, Gogineni V et al (2008) uPA/uPAR downregulation inhibits radiation-induced migration, invasion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo. Int J Oncol 33(5):937–947PubMed

26.

Cao Q, Cai W, Li T et al (2006) Combination of integrin siRNA and irradiation for breast cancer therapy. Biochem Biophys Res Commun 351(3):726–732PubMedCrossRef

27.

Sasaki MS (2009) Advances in the biophysical and molecular bases of radiation cytogenetics. Int J Radiat Biol 85(1):26–47PubMedCrossRef

28.

Iliakis G, Wang H, Perrault AR et al (2004) Mechanisms of DNA double strand break repair and chromosome aberration formation. Cytogenet Genome Res 104(1–4):14–20PubMedCrossRef

29.

Löbrich M, Rydberg B, Cooper PK (1995) Repair of X-ray-induced DNA double-strand breaks in specific Not I restriction fragments in human fibroblasts: joining of correct and incorrect ends. Proc Natl Acad Sci USA 92(26):12050–12054PubMedCrossRef

30.

Zhang X, Succi J, Feng Z, Prithivirajsingh S, Story MD, Legerski RJ (2004) Artemis is a phosphorylation target of ATM and ATR and is involved in the G2/M DNA damage checkpoint response. Mol Cell Biol 24(20):9207–9220PubMedCrossRef

31.

Xue L, Yu D, Furusawa Y et al (2009) Regulation of ATM in DNA double strand break repair accounts for the radiosensitivity in human cells exposed to high linear energy transfer ionizing radiation. Mutat Res 670(1–2):15–23PubMed

32.

Choudhury A, Cuddihy A, Bristow RG (2006) Radiation and new molecular agents part I: targeting ATM-ATR checkpoints, DNA repair, and the proteasome. Semin Radiat Oncol 16(1):51–58PubMedCrossRef

33.

Ivanov VN, Zhou H, Partridge MA, Hei TK (2009) Inhibition of ataxia telangiectasia mutated kinase activity enhances TRAIL-mediated apoptosis in human melanoma cells. Cancer Res 69(8):3510–3519PubMedCrossRef

34.

Harney J, Short SC, Shah N, Joiner M, Saunders MI (2004) Low dose hyper-radiosensitivity in metastatic tumors. Int J Radiat Oncol Biol Phys 59(4):1190–1195PubMedCrossRef

35.

Enns L, Bogen KT, Wizniak J, Murtha AD, Weinfeld M (2004) Low-dose radiation hypersensitivity is associated with p53-dependent apoptosis. Mol Cancer Res 2(10):557–566PubMed

36.

Nagasawa H, Little JB (1992) Induction of sister chromatid exchanges by extremely low doses of alpha-particles. Cancer Res 52(22):6394–6396PubMed

37.

Ojima M, Ban N, Kai M (2008) DNA double-strand breaks induced by very low X-ray doses are largely due to bystander effects. Radiat Res 170(3):365–371PubMedCrossRef

38.

Nagasawa H, Cremesti A, Kolesnick R, Fuks Z, Little JB (2002) Involvement of membrane signaling in the bystander effect in irradiated cells. Cancer Res 62(9):2531–2534PubMed

39.

Lehnert BE, Goodwin EH, Deshpande A (1997) Extracellular factor(s) following exposure to alpha particles can cause sister chromatid exchanges in normal human cells. Cancer Res 57(11):2164–2171PubMed

40.

Narayanan PK, Goodwin EH, Lehnert BE (1997) Alpha particles initiate biological production of superoxide anions and hydrogen peroxide in human cells. Cancer Res 57(18):3963–3971PubMed

41.

Wu LJ, Randers-Pehrson G, Xu A et al (1999) Targeted cytoplasmic irradiation with alpha particles induces mutations in mammalian cells. Proc Natl Acad Sci USA 96(9):4959–4964PubMedCrossRef

42.

Matsumoto H, Hayashi S, Hatashita M et al (2001) Induction of radioresistance by a nitric oxide-mediated bystander effect. Radiat Res 155(3):387–396PubMedCrossRef

43.

44.

Kamochi N, Nakashima M, Aoki S et al (2008) Irradiated fibroblast-induced bystander effects on invasive growth of squamous cell carcinoma under cancer-stromal cell interaction. Cancer Sci 99(12):2417–2427PubMedCrossRef

45.

Yacoub A, Park JS, Qiao L, Dent P, Hagan MP (2001) MAPK dependence of DNA damage repair: ionizing radiation and the induction of expression of the DNA repair genes XRCC1 and ERCC1 in DU145 human prostate carcinoma cells in a MEK1/2 dependent fashion. Int J Radiat Biol 77(10):1067–1078PubMedCrossRef

46.

Golding SE, Rosenberg E, Neill S, Dent P, Povirk LF, Valerie K (2007) Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response. Cancer Res 67(3):1046–1053PubMedCrossRef

47.

Grant S, Qiao L, Dent P (2002) Roles of ERBB family receptor tyrosine kinases, and downstream signaling pathways, in the control of cell growth and survival. Front Biosci 7:d376–d389PubMedCrossRef

48.

Warenius HM, Jones MD, Thompson CC (1996) Exit from G2 phase after 2 Gy gamma irradiation is faster in radiosensitive human cells with high expression of the RAF1 proto-oncogene. Radiat Res 146(5):485–493PubMedCrossRef

49.

Carapancea M, Cosaceanu D, Budiu R et al (2007) Dual targeting of IGF-1R and PDGFR inhibits proliferation in high-grade gliomas cells and induces radiosensitivity in JNK-1 expressing cells. J Neurooncol 85(3):245–254PubMedCrossRef

50.

Bulgin D, Podtcheko A, Takakura S et al (2006) Selective pharmacologic inhibition of c-Jun NH2-terminal kinase radiosensitizes thyroid anaplastic cancer cell lines via induction of terminal growth arrest. Thyroid 16(3):217–224PubMedCrossRef

51.

Wang X, McGowan CH, Zhao M et al (2000) Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest. Mol Cell Biol 20(13):4543–4552PubMedCrossRef

52.

Schuurbiers OC, Kaanders JH, van der Heijden HF, Dekhuijzen RP, Oyen WJ, Bussink J (2009) The PI3-K/AKT-pathway and radiation resistance mechanisms in non-small cell lung cancer. J Thorac Oncol 4(6):761–767PubMedCrossRef

53.

Leverrier Y, Thomas J, Mathieu AL, Low W, Blanquier B, Marvel J (1999) Role of PI3-kinase in Bcl-X induction and apoptosis inhibition mediated by IL-3 or IGF-1 in Baf-3 cells. Cell Death Differ 6(3):290–296PubMedCrossRef

54.

Fujita E, Jinbo A, Matuzaki H, Konishi H, Kikkawa U, Momoi T (1999) Akt phosphorylation site found in human caspase-9 is absent in mouse caspase-9. Biochem Biophys Res Commun 264(2):550–555PubMedCrossRef

55.

Li Y, Tennekoon GI, Birnbaum M, Marchionni MA, Rutkowski JL (2001) Neuregulin signaling through a PI3K/Akt/Bad pathway in Schwann cell survival. Mol Cell Neurosci 17(4):761–767PubMedCrossRef

56.

Gupta AK, Bakanauskas VJ, Cerniglia GJ et al (2001) The Ras radiation resistance pathway. Cancer Res 61(10):4278–4282PubMed

57.

Choi JA, Park MT, Kang CM et al (2004) Opposite effects of Ha-Ras and Ki-Ras on radiation-induced apoptosis via differential activation of PI3K/Akt and Rac/p38 mitogen-activated protein kinase signaling pathways. Oncogene 23(1):9–20PubMedCrossRef

58.

Rodemann HP, Dittmann K, Toulany M (2007) Radiation-induced EGFR-signaling and control of DNA-damage repair. Int J Radiat Biol 83(11–12):781–791PubMedCrossRef

59.

Toulany M, Kasten-Pisula U, Brammer I et al (2006) Blockage of epidermal growth factor receptor-phosphatidylinositol 3-kinase-AKT signaling increases radiosensitivity of K-RAS mutated human tumor cells in vitro by affecting DNA repair. Clin Cancer Res 12(13):4119–4126PubMedCrossRef

60.

Chakravarti A, Loeffler JS, Dyson NJ (2002) Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling. Cancer Res 62(1):200–207PubMed

61.

Valerie K, Yacoub A, Hagan MP et al (2007) Radiation-induced cell signaling: inside-out and outside-in. Mol Cancer Ther 6(3):789–801PubMedCrossRef

62.

Rofstad EK (2000) Microenvironment-induced cancer metastasis. Int J Radiat Biol 76(5):589–605PubMedCrossRef

63.

Guerra LE, Smith RM, Kaminski A, Lagios MD, Silverstein MJ (2008) Invasive local recurrence increased after radiation therapy for ductal carcinoma in situ. Am J Surg 196(4):552–555PubMedCrossRef

64.

Chung YL, Jian JJ, Cheng SH et al (2006) Sublethal irradiation induces vascular endothelial growth factor and promotes growth of hepatoma cells: implications for radiotherapy of hepatocellular carcinoma. Clin Cancer Res 12(9):2706–2715PubMedCrossRef

65.

Camphausen K, Moses MA, Beecken WD, Khan MK, Folkman J, O’Reilly MS (2001) Radiation therapy to a primary tumor accelerates metastatic growth in mice. Cancer Res 61(5):2207–2211PubMed

66.

Rofstad EK, Mathiesen B, Galappathi K (2004) Increased metastatic dissemination in human melanoma xenografts after subcurative radiation treatment: radiation-induced increase in fraction of hypoxic cells and hypoxia-induced up-regulation of urokinase-type plasminogen activator receptor. Cancer Res 64(1):13–18PubMedCrossRef

67.

Tsukamoto H, Shibata K, Kajiyama H, Terauchi M, Nawa A, Kikkawa F (2007) Irradiation-induced epithelial-mesenchymal transition (EMT) related to invasive potential in endometrial carcinoma cells. Gynecol Oncol 107(3):500–504PubMedCrossRef

68.

Andarawewa KL, Erickson AC, Chou WS et al (2007) Ionizing radiation predisposes nonmalignant human mammary epithelial cells to undergo transforming growth factor beta induced epithelial to mesenchymal transition. Cancer Res 67(18):8662–8670PubMedCrossRef

69.

Jung JW, Hwang SY, Hwang JS, Oh ES, Park S, Han IO (2007) Ionising radiation induces changes associated with epithelial-mesenchymal transdifferentiation and increased cell motility of A549 lung epithelial cells. Eur J Cancer 43(7):1214–1224PubMedCrossRef

70.

Hwang SY, Jung JW, Jeong JS et al (2006) Dominant-negative Rac increases both inherent and ionizing radiation-induced cell migration in C6 rat glioma cells. Int J Cancer 118(8):2056–2063PubMedCrossRef

71.

Baluna RG, Eng TY, Thomas CR (2006) Adhesion molecules in radiotherapy. Radiat Res 166(6):819–831PubMedCrossRef

72.

Albert JM, Cao C, Geng L, Leavitt L, Hallahan DE, Lu B (2006) Integrin alpha v beta 3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models. Int J Radiat Oncol Biol Phys 65(5):1536–1543PubMed

73.

Monferran S, Skuli N, Delmas C et al (2008) Alphavbeta3 and alphavbeta5 integrins control glioma cell response to ionising radiation through ILK and RhoB. Int J Cancer 123(2):357–364PubMedCrossRef

74.

Monnier Y, Farmer P, Bieler G et al (2008) CYR61 and alphaVbeta5 integrin cooperate to promote invasion and metastasis of tumors growing in preirradiated stroma. Cancer Res 68(18):7323–7331PubMedCrossRef

75.

Lakka SS, Gondi CS, Rao JS (2005) Proteases and glioma angiogenesis. Brain Pathol 15(4):327–341PubMedCrossRef

76.

Rao JS (2003) Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3(7):489–501PubMedCrossRef

77.

Qian LW, Mizumoto K, Urashima T et al (2002) Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023. Clin Cancer Res 8(4):1223–1227PubMed

78.

Trog D, Yeghiazaryan K, Fountoulakis M et al (2006) Pro-invasive gene regulating effect of irradiation and combined temozolomide-radiation treatment on surviving human malignant glioma cells. Eur J Pharmacol 542(1–3):8–15PubMedCrossRef

79.

Speake WJ, Dean RA, Kumar A, Morris TM, Scholefield JH, Watson SA (2005) Radiation induced MMP expression from rectal cancer is short lived but contributes to in vitro invasion. Eur J Surg Oncol 3(8):869–874CrossRef

80.

Cordes N, Hansmeier B, Beinke C, Meineke V, van Beuningen D (2003) Irradiation differentially affects substratum-dependent survival, adhesion, and invasion of glioblastoma cell lines. Br J Cancer 89(11):2122–2132PubMedCrossRef

81.

Chetty C, Bhoopathi P, Rao JS, Lakka SS (2009) Inhibition of matrix metalloproteinase-2 enhances radiosensitivity by abrogating radiation-induced FoxM1-mediated G2/M arrest in A549 lung cancer cells. Int J Cancer 124(10):2468–2477PubMedCrossRef

82.

Paquette B, Baptiste C, Therriault H, Arguin G, Plouffe B, Lemay R (2007) In vitro irradiation of basement membrane enhances the invasiveness of breast cancer cells. Br J Cancer 97(11):1505–1512PubMedCrossRef

83.

Wei LH, Lai KP, Chen CA et al (2005) Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor kappaB. Oncogene 24(3):390–398PubMedCrossRef

84.

Gogineni VR, Kargiotis O, Klopfenstein JD, Gujrati M, Dinh DH, Rao JS (2009) RNAi-mediated downregulation of radiation-induced MMP-9 leads to apoptosis via activation of ERK and Akt in IOMM-Lee cells. Int J Oncol 34(1):209–218PubMed

85.

Jadhav U, Mohanam S (2006) Response of neuroblastoma cells to ionizing radiation: modulation of in vitro invasiveness and angiogenesis of human microvascular endothelial cells. Int J Oncol 29(6):1525–1531PubMed

86.

Zhai GG, Malhotra R, Delaney M et al (2006) Radiation enhances the invasive potential of primary glioblastoma cells via activation of the Rho signaling pathway. J Neurooncol 76(3):227–237PubMedCrossRef

87.

Wick W, Wick A, Schulz JB, Dichgans J, Rodemann HP, Weller M (2002) Prevention of irradiation-induced glioma cell invasion by temozolomide involves caspase 3 activity and cleavage of focal adhesion kinase. Cancer Res 62(6):1915–1919PubMed

88.

Ohuchida K, Mizumoto K, Murakami M et al (2004) Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. Cancer Res 64(9):3215–3222PubMedCrossRef

89.

Rofstad EK, Mathiesen B, Henriksen K, Kindem K, Galappathi K (2005) The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products. Cancer Res 65(6):2387–2396PubMedCrossRef

90.

Koch CJ, Kruuv J, Frey HE (1973) Variation in radiation response of mammalian cells as a function of oxygen tension. Radiat Res 53(1):33–42PubMedCrossRef

91.

Chapman JD, Dugle DL, Reuvers AP, Meeker BE, Borsa J (1974) Studies on the radiosensitizing effect of oxygen in Chinese hamster cells. Int J Radiat Biol Relat Stud Phys Chem Med 26(4):383–389PubMedCrossRef

92.

Wachsberger P, Burd R, Dicker AP (2003) Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction. Clin Cancer Res 9(6):1957–1971PubMed

93.

Giaccia AJ (1996) Hypoxic stress proteins: survival of the fittest. Semin Radiat Oncol 6(1):46–58PubMedCrossRef

94.

Gorski DH, Beckett MA, Jaskowiak NT et al (1999) Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res 59(14):3374–3378PubMed

95.

Chandel NS, McClintock DS, Feliciano CE et al (2000) Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J Biol Chem 275(33):25130–25138PubMedCrossRef

96.

Kargiotis O, Rao JS, Kyritsis AP (2006) Mechanisms of angiogenesis in gliomas. J Neurooncol 78(3):281–293PubMedCrossRef

97.

Harada H, Kizaka-Kondoh S, Li G et al (2007) Significance of HIF-1-active cells in angiogenesis and radioresistance. Oncogene 26(54):7508–7516PubMedCrossRef

98.

Moeller BJ, Cao Y, Li CY, Dewhirst MW (2004) Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. Cancer Cell 5(5):429–441PubMedCrossRef

99.

Singh-Gupta V, Zhang H, Banerjee S et al (2009) Radiation-induced HIF-1alpha cell survival pathway is inhibited by soy isoflavones in prostate cancer cells. Int J Cancer 124(7):1675–1684PubMedCrossRef

100.

Kim WY, Oh SH, Woo JK, Hong WK, Lee HY (2009) Targeting heat shock protein 90 overrides the resistance of lung cancer cells by blocking radiation-induced stabilization of hypoxia-inducible factor-1alpha. Cancer Res 69(4):1624–1632PubMedCrossRef

101.

Skuli N, Monferran S, Delmas C et al (2009) Alphavbeta3/alphavbeta5 integrins-FAK-RhoB: a novel pathway for hypoxia regulation in glioblastoma. Cancer Res 69(8):3308–3316PubMedCrossRef

102.

Kaliski A, Maggiorella L, Cengel KA et al (2005) Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion. Mol Cancer Ther 4(11):1717–1728PubMedCrossRef

103.

Parthymou A, Kardamakis D, Pavlopoulos I, Papadimitriou E (2004) Irradiated C6 glioma cells induce angiogenesis in vivo and activate endothelial cells in vitro. Int J Cancer 110(6):807–814PubMedCrossRef

104.

Solberg TD, Nearman J, Mullins J, Li S, Baranowska-Kortylewicz J (2008) Correlation between tumor growth delay and expression of cancer and host VEGF, VEGFR2, and osteopontin in response to radiotherapy. Int J Radiat Oncol Biol Phys 72(3):918–926PubMed

105.

Nojiri K, Iwakawa M, Ichikawa Y et al (2009) The proangiogenic factor ephrin-A1 is up-regulated in radioresistant murine tumor by irradiation. Exp Biol Med 234(1):112–122CrossRef

106.

Tabatabai G, Frank B, Wick A et al (2007) Synergistic antiglioma activity of radiotherapy and enzastaurin. Ann Neurol 61(2):153–161PubMedCrossRef

107.

Kumar P, Benedict R, Urzua F, Fischbach C, Mooney D, Polverini P (2005) Combination treatment significantly enhances the efficacy of antitumor therapy by preferentially targeting angiogenesis. Lab Invest 85(6):756–767PubMedCrossRef

108.

Abdollahi A, Griggs DW, Zieher H et al (2005) Inhibition of alpha(v)beta3 integrin survival signaling enhances antiangiogenic and antitumor effects of radiotherapy. Clin Cancer Res 11(17):6270–6279PubMedCrossRef

109.

Chen CH, Hung HS, Hsu SH (2008) Low-energy laser irradiation increases endothelial cell proliferation, migration, and eNOS gene expression possibly via PI3K signal pathway. Lasers Surg Med 40(1):46–54PubMedCrossRef

110.

Sonveaux P, Dessy C, Brouet A et al (2002) Modulation of the tumor vasculature functionality by ionizing radiation accounts for tumor radiosensitization and promotes gene delivery. FASEB J 16(14):1979–1981PubMed

111.

Annabi B, Lee YT, Martel C, Pilorget A, Bahary JP, Béliveau R (2003) Radiation induced-tubulogenesis in endothelial cells is antagonized by the antiangiogenic properties of green tea polyphenol (−) epigallocatechin-3-gallate. Cancer Biol Ther 2(6):642–649PubMed

112.

Bozec A, Formento P, Ciccolini J et al (2005) Response of endothelial cells to a dual tyrosine kinase receptor inhibition combined with irradiation. Mol Cancer Ther 4(12):1962–1971PubMedCrossRef

113.

Choy H, Milas L (2003) Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: a rational advance? J Natl Cancer Inst 95(19):1440–1452PubMed

114.

Ahmad M, Khurana NR, Jaberi JE (2007) Ionizing radiation decreases capillary-like structure formation by endothelial cells in vitro. Microvasc Res 73(1):14–19PubMedCrossRef

115.

Mao XW (2006) A quantitative study of the effects of ionizing radiation on endothelial cells and capillary-like network formation. Technol Cancer Res Treat 5(2):127–134PubMed

116.

Svagzdys S, Lesauskaite V, Pavalkis D, Nedzelskiene I, Pranys D, Tamelis A (2009) Microvessel density as new prognostic marker after radiotherapy in rectal cancer. BMC Cancer 9:95PubMedCrossRef

117.

Tsai JH, Makonnen S, Feldman M, Sehgal CM, Maity A, Lee WM (2005) Ionizing radiation inhibits tumor neovascularization by inducing ineffective angiogenesis. Cancer Biol Ther 4(12):1395–1400CrossRef

118.

Scharpfenecker M, Kruse JJ, Sprong D, Russell NS, Ten Dijke P, Stewart FA (2009) Ionizing radiation shifts the PAI-1/ID-1 balance and activates notch signaling in endothelial cells. Int J Radiat Oncol Biol Phys 73(2):506–513PubMed

119.

Senan S, Smit EF (2007) Design of clinical trials of radiation combined with antiangiogenic therapy. Oncologist 12(4):465–477PubMedCrossRef

120.

Timke C, Zieher H, Roth A et al (2008) Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy. Clin Cancer Res 14(7):2210–2219PubMedCrossRef

121.

Shibuya K, Komaki R, Shintani T et al (2007) Targeted therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic model of human non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 69(5):1534–1543PubMed

122.

Lee CG, Heijn M, di Tomaso E et al (2000) Anti-vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Res 60(19):5565–5570PubMed

123.

Shannon AM, Williams KJ (2008) Antiangiogenics and radiotherapy. J Pharm Pharmacol 60(8):1029–1036PubMedCrossRef

124.

Winkler F, Kozin SV, Tong RT et al (2004) Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 6(6):553–563PubMed

125.

Itasaka S, Komaki R, Herbst RS et al (2007) Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice. Int J Radiat Oncol Biol Phys 67(3):870–878PubMed

126.

Viani GA, Manta GB, Fonseca EC, De Fendi LI, Afonso SL, Stefano EJ (2009) Whole brain radiotherapy with radiosensitizer for brain metastases. J Exp Clin Cancer Res 28:1PubMedCrossRef

127.

Spiotto MT, Fu YX, Schreiber H (2003) Tumor immunity meets autoimmunity: antigen levels and dendritic cell maturation. Curr Opin Immunol 15(6):725–730PubMedCrossRef

128.

Dunn GP, Bruce AT, Ikeda H et al (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3(11):991–998PubMedCrossRef

129.

Kim KW, Kim SH, Shin JG et al (2004) Direct injection of immature dendritic cells into irradiated tumor induces efficient antitumor immunity. Int J Cancer 109(5):685–690PubMedCrossRef

130.

Ishihara H, Tsuneoka K, Dimchev AB et al (1993) Induction of the expression of the interleukin-1 beta gene in mouse spleen by ionizing radiation. Radiat Res 133(3):321–326PubMedCrossRef

131.

Rieser C, Bock G, Klocker H et al (1997) Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production. J Exp Med 186(9):1603–1608PubMedCrossRef

132.

Demaria S, Bhardwaj N, McBride WH, Formenti SC (2005) Combining radiotherapy and immunotherapy: a revived partnership. Int J Radiat Oncol Biol Phys 63(3):655–666PubMed

133.

Senzer N, Mani S, Rosemurgy A et al (2004) TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors. J Clin Oncol 22(4):592–601PubMedCrossRef

134.

Gulley JL, Arlen PM, Bastian N et al (2005) Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer. Clin Cancer Res 11(90):3353–3362PubMedCrossRef

135.

De Schutter H, Nuyts S (2009) Radiosensitizing potential of epigenetic anticancer drugs. Anticancer Agents Med Chem 9(1):99–108PubMed

136.

Camphausen K, Tofilon PJ (2007) Inhibition of histone deacetylation: a strategy for tumor radiosensitization. J Clin Oncol 25(26):4051–4056PubMedCrossRef

137.

Harrington KJ, Melcher A, Vassaux G, Pandha HS, Vile RG (2008) Exploiting synergies between radiation and oncolytic viruses. Curr Opin Mol Ther 10(4):362–370PubMed

138.

Advani SJ, Weichselbaum RR, Chmura SJ (2007) Enhancing radiotherapy with genetically engineered viruses. J Clin Oncol 25(26):4090–4095PubMedCrossRef

139.

Robson T, Worthington J, McKeown SR, Hirst DG (2005) Radiogenic therapy: novel approaches for enhancing tumor radiosensitivity. Technol Cancer Res Treat 4(4):343–361PubMed

140.

Belka C, Jendrossek V, Pruschy M, Vink S, Verheij M, Budach W (2004) Apoptosis-modulating agents in combination with radiotherapy—current status and outlook. Int J Radiat Oncol Biol Phys 58(2):542–554PubMed

141.

Heath VL, Bicknell R (2009) Anticancer strategies involving the vasculature. Nat Rev Clin Oncol 6(7):395–404PubMedCrossRef

142.

Willett CG, Duda DG, di Tomaso E et al (2009) Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study. J Clin Oncol 27(18):3020–3026PubMedCrossRef

143.

Zhao JD, Liu J, Ren ZG et al (2010) Maintenance of sorafenib following combined therapy of three-dimensional conformal radiation therapy/intensity-modulated radiation therapy and transcatheter arterial chemoembolization in patients with locally advanced hepatocellular carcinoma: a phase I/II study. Radiat Oncol 5(1):12PubMedCrossRef

144.

Overgaard J, Horsman MR (1996) Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers. Semin Radiat Oncol 6(1):10–21PubMedCrossRef

Title: Effects of irradiation on tumor cell survival, invasion and angiogenesis
Authors: Odysseas Kargiotis
Aliki Geka
Jasti S. Rao
Athanasios P. Kyritsis
Publication date: 01-12-2010
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 3/2010
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-010-0199-4

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Effects of irradiation on tumor cell survival, invasion and angiogenesis

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2010

MGMT promoter methylation status in anaplastic meningiomas

Tonsillar pseudotumor: complications of chronically-administered temozolomide

Surgical treatment of high-grade gliomas in motor areas. The impact of different supportive technologies: a 171-patient series

Extramedullary hematopoiesis within the clivus: an unusual cause of lower cranial nerve palsy

Clinical outcomes of adult patients with primary intracranial germinomas treated with low-dose craniospinal radiotherapy and local boost

Expression of phosphoprotein enriched in astrocytes 15 kDa (PEA-15) in astrocytic tumors: a novel approach of correlating malignancy grade and prognosis